These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 17575150)
1. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases. Zhao Y; Bachelier R; Treilleux I; Pujuguet P; Peyruchaud O; Baron R; Clément-Lacroix P; Clézardin P Cancer Res; 2007 Jun; 67(12):5821-30. PubMed ID: 17575150 [TBL] [Abstract][Full Text] [Related]
2. The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression. Takayama S; Ishii S; Ikeda T; Masamura S; Doi M; Kitajima M Anticancer Res; 2005; 25(1A):79-83. PubMed ID: 15816522 [TBL] [Abstract][Full Text] [Related]
3. A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden. Le Gall C; Bellahcène A; Bonnelye E; Gasser JA; Castronovo V; Green J; Zimmermann J; Clézardin P Cancer Res; 2007 Oct; 67(20):9894-902. PubMed ID: 17942921 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer. Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer. Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326 [TBL] [Abstract][Full Text] [Related]
6. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line. Price JT; Quinn JM; Sims NA; Vieusseux J; Waldeck K; Docherty SE; Myers D; Nakamura A; Waltham MC; Gillespie MT; Thompson EW Cancer Res; 2005 Jun; 65(11):4929-38. PubMed ID: 15930315 [TBL] [Abstract][Full Text] [Related]
7. Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo. Fournier PG; Daubiné F; Lundy MW; Rogers MJ; Ebetino FH; Clézardin P Cancer Res; 2008 Nov; 68(21):8945-53. PubMed ID: 18974139 [TBL] [Abstract][Full Text] [Related]
8. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells. Borrirukwanit K; Lafleur MA; Mercuri FA; Blick T; Price JT; Fridman R; Pereira JJ; Leardkamonkarn V; Thompson EW Matrix Biol; 2007 May; 26(4):291-305. PubMed ID: 17175151 [TBL] [Abstract][Full Text] [Related]
9. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180 [TBL] [Abstract][Full Text] [Related]
11. Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically. Fisher JL; Thomas-Mudge RJ; Elliott J; Hards DK; Sims NA; Slavin J; Martin TJ; Gillespie MT Cancer Res; 2006 Apr; 66(7):3620-8. PubMed ID: 16585187 [TBL] [Abstract][Full Text] [Related]
12. Cilengitide inhibits metastatic bone colonization in a nude rat model. Bretschi M; Merz M; Komljenovic D; Berger MR; Semmler W; Bäuerle T Oncol Rep; 2011 Oct; 26(4):843-51. PubMed ID: 21725616 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor formation by snake venom disintegrin. Yang RS; Tang CH; Chuang WJ; Huang TH; Peng HC; Huang TF; Fu WM Toxicon; 2005 Apr; 45(5):661-9. PubMed ID: 15777962 [TBL] [Abstract][Full Text] [Related]
14. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity. Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709 [TBL] [Abstract][Full Text] [Related]
15. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model. Zhang JH; Tang J; Wang J; Ma W; Zheng W; Yoneda T; Chen J Int J Oncol; 2003 Oct; 23(4):1043-8. PubMed ID: 12963984 [TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715 [TBL] [Abstract][Full Text] [Related]
17. Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone. Tamura D; Hiraga T; Myoui A; Yoshikawa H; Yoneda T Int J Oncol; 2008 Jul; 33(1):17-24. PubMed ID: 18575746 [TBL] [Abstract][Full Text] [Related]
18. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621 [TBL] [Abstract][Full Text] [Related]
19. Osteoclasts direct bystander killing of cancer cells in vitro. Ramnaraine M; Pan W; Clohisy DR Bone; 2006 Jan; 38(1):4-12. PubMed ID: 16139579 [TBL] [Abstract][Full Text] [Related]
20. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. Pécheur I; Peyruchaud O; Serre CM; Guglielmi J; Voland C; Bourre F; Margue C; Cohen-Solal M; Buffet A; Kieffer N; Clézardin P FASEB J; 2002 Aug; 16(10):1266-8. PubMed ID: 12153995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]